alpha-tocopherol phosphate has been researched along with ascorbic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cederbaum, AI; Chen, Q; Galleano, M | 1 |
| Ito, S; Kanazawa, H; Mori, T; Sawaguchi, T | 1 |
| Ito, S; Matsubayashi, K; Mori, T; Sawaguchi, T | 1 |
| Kawada, A; Kurokawa, I; Oiso, N | 1 |
| Azzi, A; Meydani, M; Zingg, JM | 1 |
| Ito, S; Kurokawa, I; Yoshioka, M | 1 |
1 trial(s) available for alpha-tocopherol phosphate and ascorbic acid
| Article | Year |
|---|---|
Split-face comparative clinical trial using glyceryl-octyl-ascorbic acid/ascorbyl 2-phosphate 6-palmitate/DL-α-tocopherol phosphate complex treatment for postinflammatory hyperpigmentation, postinflammatory erythema and atrophic scar in acne vulgaris.
Topics: Acne Vulgaris; Adult; alpha-Tocopherol; Ascorbic Acid; Cicatrix; Cosmeceuticals; Drug Combinations; Erythema; Female; Glyceryl Ethers; Humans; Hyperpigmentation; Male; Skin Cream; Treatment Outcome; Young Adult | 2019 |
5 other study(ies) available for alpha-tocopherol phosphate and ascorbic acid
| Article | Year |
|---|---|
Cytotoxicity and apoptosis produced by arachidonic acid in Hep G2 cells overexpressing human cytochrome P4502E1.
Topics: alpha-Tocopherol; Antioxidants; Apoptosis; Ascorbic Acid; Aspirin; Carcinoma, Hepatocellular; Cell Survival; Chromans; Cytochrome P-450 CYP2E1; Deferoxamine; Humans; L-Lactate Dehydrogenase; Liver Neoplasms; Oleic Acid; Phenylenediamines; Propyl Gallate; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Vitamin E | 1997 |
Differential effects of the ascorbyl and tocopheryl derivative on the methamphetamine-induced toxic behavior and toxicity.
Topics: alpha-Tocopherol; Animals; Antioxidants; Ascorbic Acid; Central Nervous System Stimulants; Dopamine; Electron Spin Resonance Spectroscopy; Free Radicals; Iron-Binding Proteins; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Molecular Structure; Morphine; Neurotoxicity Syndromes; Self-Injurious Behavior | 2007 |
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Enzyme Inhibitors; Free Radical Scavengers; Hydroxyl Radical; Male; Mice; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Phospholipase A2 Inhibitors; Substance Withdrawal Syndrome; Superoxides | 2007 |
Adjuvant alternative treatment with chemical peeling and subsequent iontophoresis for postinflammatory hyperpigmentation, erosion with inflamed red papules and non-inflamed atrophic scars in acne vulgaris.
Topics: Acne Vulgaris; Adapalene; Adolescent; Adult; alpha-Tocopherol; Anti-Infective Agents; Ascorbic Acid; Atrophy; Benzoyl Peroxide; Chemexfoliation; Cicatrix; Clindamycin; Combined Modality Therapy; Erythema; Female; Glycolates; Humans; Hyperpigmentation; Iontophoresis; Japan; Male; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
α-Tocopheryl Phosphate Induces VEGF Expression via CD36/PI3Kγ in THP-1 Monocytes.
Topics: alpha-Tocopherol; Ascorbic Acid; CD36 Antigens; Cell Line, Tumor; Class Ib Phosphatidylinositol 3-Kinase; HEK293 Cells; Humans; Macrophages; Monocytes; Phagocytosis; Signal Transduction; Staphylococcus aureus; THP-1 Cells; Vascular Endothelial Growth Factor A; Vitamin E | 2017 |